SEC Tracker
Get the app

Biogen BIIB

Jane Grogan (Head of Research) received 695 BIIB in vested stock units

Form
4
Filed
Importance
Routine
  1. Held 4,408 shares after transaction
  2. Restricted stock units (shares paid out over time) vest in 2026

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Biogen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  2. INSMED INSM public float $21.1B, Jun 30, 2025
  3. BeOne Medicines ONC public float $14.7B, Jun 30, 2025
  4. United Therapeutics UTHR public float $11.2B, Jun 30, 2025
  5. Roivant Sciences ROIV public float $9.8B, Sep 30, 2025